B2B COVID Articles

  • Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19

    Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19

    New research shows early intervention could slow the progression of COVID-19.

    Read Article
  • Remdesivir for 5 to 10 days in Patients with Severe COVID-19

    Remdesivir for 5 to 10 days in Patients with Severe COVID-19

    Patients with severe cases of COVID-19 were treated with Remdesivir for 5 and 10 days to determine efficacy of the duration of treatment.

    Read Article
  • Immunological manipulations to lessen the severity of COVID-19

    Immunological manipulations to lessen the severity of COVID-19

    Article featuring multiple Providence doctors published in the Journal for ImmunoTherapy of Cancer focused on immunological manipulations to lessen the severity of COVID-19.

    Read Article
  • Clinical Support: An Unconventional Request – Providence’s 100 Million Masks Initiative

    Clinical Support: An Unconventional Request – Providence’s 100 Million Masks Initiative

    How the clinical support team at Providence met an unprecedented challenge.

    Read Article
  • NEJM: First Case of 2019 Novel Coronavirus in the United States

    NEJM: First Case of 2019 Novel Coronavirus in the United States

    This report covers the first case of 2019-nCoV infection confirmed in the United States and describes the identification, diagnosis, clinical course, and management of the case.

    Read Article
  • Insights from immuno-oncology

    Insights from immuno-oncology

    The Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.

    Read Article
  • Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic

    Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic

    This document identifies the potential risks of exposure to patients, allied health care staff, industry representatives and hospital administrators.

    Read Article
  • Put a lid on it: Are faecal bio-aerosols a route of transmission for SARS-CoV-2?

    Put a lid on it: Are faecal bio-aerosols a route of transmission for SARS-CoV-2?

    Gastrointestinal manifestations of COVID-19 are immediately reminiscent of previous coronavirus outbreaks and should raise concern about faecal shedding as a mode of transmission.

    Read Article
  • Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States

    Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States

    Described in this case series are the first 12 US patients confirmed to have COVID-19 from January 20 to February 5, 2020.

    Read Article
  • NEJM: Covid-19 in Critically Ill Patients in the Seattle Region — Case Series

    NEJM: Covid-19 in Critically Ill Patients in the Seattle Region — Case Series

    This study in the New England Journal of medicine examines clinical data from 24 COVID positive patients.

    Read Article
  • loading
    Loading More...